Semaglutide structure
Semaglutide
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes.
Find 53 Related Holders
Qilu Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Inactive
-
Founded in:
1992-08-21 -
Country:
China -
Address:
No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province -
Tax NO.:
91370000614073351Q -
Registered Funds:
600 million yuan -
Website:
-
Email:
Suzhou Tianma PHARMA Group Tianji BIO-PHARMACEUTICAL Co., Ltd.
China
China
API Registration Country
API Inactive
-
Founded in:
2000-06-21 -
Country:
China -
Address:
No. 199, Huayuan East Road, Mudu Town, Wuzhong District, Suzhou City -
Tax NO.:
91320506720538941C -
Registered Funds:
220 million yuan -
Website:
-
Email:
ShanxiTongda Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Inactive
-
Founded in:
1997-05-30 -
Country:
China -
Address:
The First Pharmaceutical Industrial Park, Datong Economic Development Zone -
Tax NO.:
911402006020035321 -
Registered Funds:
50 million yuan -
Website:
-
Email:
Recommended Suppliers of Semaglutide
-
Tianjin Jinshu Technology Co., Ltd.
CN1 YR
Contact Supplier -
Dingwang Technology (Wuhan) Co., Ltd.
CN1 YR
Contact Supplier -
QingDao NuoChenJian Technology Co.,LTD
CN1 YR
Contact Supplier -
SYS Pharma Corp.
CN1 YR
Contact Supplier -
Tianjin Apex Import and Export Trading Co., Ltd.
CN1 YR
Contact Supplier